Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06452277
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-05
Brief Title:
A Study to Learn More About How Well BAY 2927088 Works and How Safe it is Compared With Standard Treatment in Participants Who Have Advanced Non-small Cell Lung Cancer NSCLC With Mutations in the Genes of Human Epidermal Growth Factor Receptor 2 HER2
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
22615
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None